Moringa Powder Linked to Multistate Salmonella Outbreak

Got story updates? Submit your updates here. ›

Federal regulators have warned of a multistate outbreak of a highly drug-resistant salmonella infection linked to moringa powder supplements from Ambrosia Brands LLC. At least seven people across seven states were infected with the outbreak strain between November and January, with three hospitalizations reported. The FDA says the salmonella strain is resistant to all common antibiotics used to treat such infections.

Why it matters

Moringa powder has surged in popularity as a trendy 'superfood' supplement, but this outbreak highlights the potential health risks associated with some dietary supplements, especially when they are contaminated with antibiotic-resistant bacteria. The spread of this outbreak across multiple states also raises concerns about the distribution and regulation of these types of products.

The details

The FDA's traceback investigation has linked the outbreak to certain Rosabella-brand moringa powder capsules distributed nationwide by Ambrosia Brands LLC. The company has agreed to recall the affected lots, which were sold through their direct-to-consumer website, TikTok Shop, and potentially unauthorized third-party sellers. Regulators warn consumers who purchased the recalled lots should dispose of the product and not consume, sell or distribute it.

• The outbreak occurred between November 7, 2025 and January 8, 2026.
• Ambrosia Brands issued the recall in February 2026.

What’s next

The FDA and CDC will continue to monitor the situation and investigate the source of the outbreak. Ambrosia Brands has agreed to the recall, and consumers who purchased the affected lots are advised to dispose of the product.